West Pharmaceutical Services, Inc. (WST) Position Lifted by Pier Capital LLC

Pier Capital LLC increased its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 1.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 61,782 shares of the medical instruments supplier’s stock after acquiring an additional 917 shares during the quarter. Pier Capital LLC owned about 0.08% of West Pharmaceutical Services worth $5,947,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Acrospire Investment Management LLC bought a new position in West Pharmaceutical Services during the 2nd quarter worth approximately $113,000. Citigroup Inc. boosted its stake in West Pharmaceutical Services by 95.1% during the 2nd quarter. Citigroup Inc. now owns 1,569 shares of the medical instruments supplier’s stock worth $148,000 after acquiring an additional 765 shares during the last quarter. Wolverine Trading LLC bought a new position in West Pharmaceutical Services in the second quarter valued at approximately $200,000. Nomura Holdings Inc. bought a new position in West Pharmaceutical Services in the second quarter valued at approximately $201,000. Finally, Grandfield & Dodd LLC bought a new position in West Pharmaceutical Services in the third quarter valued at approximately $201,000. 93.28% of the stock is currently owned by institutional investors and hedge funds.

Shares of West Pharmaceutical Services, Inc. (WST) traded up $0.28 on Tuesday, reaching $99.39. 344,600 shares of the company’s stock were exchanged, compared to its average volume of 363,565. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.87 and a current ratio of 2.59. West Pharmaceutical Services, Inc. has a 1 year low of $77.97 and a 1 year high of $103.36. The company has a market capitalization of $7,359.21, a price-to-earnings ratio of 42.72, a P/E/G ratio of 2.11 and a beta of 1.11.

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings results on Thursday, October 26th. The medical instruments supplier reported $0.67 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.53 by $0.14. West Pharmaceutical Services had a net margin of 12.12% and a return on equity of 14.47%. The firm had revenue of $398.20 million for the quarter, compared to analyst estimates of $386.02 million. During the same quarter in the previous year, the firm posted $0.53 earnings per share. The business’s revenue was up 5.7% on a year-over-year basis. research analysts forecast that West Pharmaceutical Services, Inc. will post 2.76 EPS for the current year.

A number of research analysts have weighed in on WST shares. Jefferies Group raised shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and lifted their price target for the company from $96.00 to $115.00 in a research note on Friday, September 15th. Stephens started coverage on shares of West Pharmaceutical Services in a research note on Tuesday, October 3rd. They issued an “equal weight” rating and a $99.00 price target on the stock. Zacks Investment Research raised shares of West Pharmaceutical Services from a “sell” rating to a “hold” rating in a research note on Wednesday, September 27th. Bank of America lowered shares of West Pharmaceutical Services from a “buy” rating to a “neutral” rating and set a $98.00 price target on the stock. in a research note on Tuesday, October 17th. Finally, Wells Fargo & Company lifted their price target on shares of West Pharmaceutical Services from $105.00 to $112.00 and gave the company an “outperform” rating in a research note on Friday, October 27th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $106.00.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.chaffeybreeze.com/2017/12/05/west-pharmaceutical-services-inc-wst-position-lifted-by-pier-capital-llc.html.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply